My research focuses on better understanding which heart attack patients are at higher risk of poor outcomes and how this knowledge can improve treatment strategies.

By identifying key factors that predict worse recovery, we can help tailor care to those who need it most. This information is crucial for guiding the development and implementation of novel device-based therapies that aim to support heart recovery or limit heart muscle damage after a heart attack. Ultimately, my goal is to improve patient outcomes by combining cutting-edge technology with personalised treatment approaches, ensuring that high-risk patients receive the best possible care.

My research program is dedicated to unlocking better ways to diagnose microvascular injury and dysfunction, paving the way for more effective treatments. By refining how we identify these conditions, we can enhance care pathways and bring forward innovative therapies. This is especially crucial for patients suffering from refractory angina due to microvascular dysfunction and those at risk of heart failure after a heart attack due to microvascular obstruction. Ultimately, our goal is to turn cutting-edge research into real-world solutions, ensuring patients get the right treatment at the right time.

My research program is dedicated to unlocking better ways to treat resistant hypertension, ensuring that patients who need more than standard therapies get the right solutions at the right time. We aim to identify those most likely to benefit from mini-invasive procedures and refine how these treatments are used. By developing smarter ways to assess their effectiveness earlier, we can personalize care, improve outcomes, and optimize treatment pathways. Ultimately, our goal is to turn cutting-edge research into practical, life-changing solutions for patients with hard-to-control high blood pressure.